Cargando…
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
SIMPLE SUMMARY: Radiotherapy is an option for curing localized and locally advanced prostate cancer. However, radioresistance can occur, determining treatment failure and poor prognosis. Herein, we developed a model of radio-resistant prostate cancer cells by irradiating the bone metastasis-derived...
Autores principales: | Sideri, Silvia, Petragnano, Francesco, Maggio, Roberto, Petrungaro, Simonetta, Catizone, Angela, Gesualdi, Luisa, De Martino, Viviana, Battafarano, Giulia, Del Fattore, Andrea, Liguoro, Domenico, De Cesaris, Paola, Filippini, Antonio, Marampon, Francesco, Riccioli, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688510/ https://www.ncbi.nlm.nih.gov/pubmed/36428597 http://dx.doi.org/10.3390/cancers14225504 |
Ejemplares similares
-
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
por: Fontanella, Rosaria A., et al.
Publicado: (2021) -
Strategies for Bone Regeneration: From Graft to Tissue Engineering
por: Battafarano, Giulia, et al.
Publicado: (2021) -
Cellular and Molecular Mediators of Bone Metastatic Lesions
por: Battafarano, Giulia, et al.
Publicado: (2018) -
Bone Control of Muscle Function
por: Battafarano, Giulia, et al.
Publicado: (2020) -
ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation
por: Gesualdi, Luisa, et al.
Publicado: (2023)